ライフサイエンスコーパス: vaccine-preventable disease

1 immunization rates and prevent outbreaks of vaccine-preventable disease.

2 risk for morbidity and mortality related to vaccine-preventable disease.

3 the rates of effective immunization against vaccine preventable diseases.

4 eity in the proportion of children immune to vaccine-preventable diseases.

5 h immunization rates to prevent outbreaks of vaccine-preventable diseases.

6 's population from accessing protection from vaccine-preventable diseases.

7 tform-enabling technology applicable to most vaccine-preventable diseases.

8 otential to sustain epidemic transmission of vaccine-preventable diseases.

9 t the pregnant woman, fetus, and infant from vaccine-preventable diseases.

10 tion of all children and adolescents against vaccine-preventable diseases.

11 about vaccines, vaccination programmes, and vaccine-preventable diseases.

12 s that would put children at higher risk for vaccine-preventable diseases.

13 address HIV/AIDS, malaria, tuberculosis, and vaccine-preventable diseases.

14 to provide advice and guidance on control of vaccine-preventable diseases.

15 ical exemptions can affect community risk of vaccine-preventable diseases.

16 creased risk of contracting and transmitting vaccine-preventable diseases.

17 ve vaccine efficacy and broaden the range of vaccine-preventable diseases.

18 f cases, deaths, and hospitalizations for 13 vaccine-preventable diseases.

19 t ensure adequate protection against certain vaccine-preventable diseases.

20 ies to ensure control of pertussis and other vaccine-preventable diseases.

21 and is similar to that seen for other viral vaccine-preventable diseases.

22 tial of new vaccines into the reality of new vaccine-preventable diseases.

23 Rotavirus is now a commonly occurring vaccine-preventable disease among children in developed

24 The risk of vaccine-preventable diseases among children who have phi

25 NmB were relatively low compared with other vaccine-preventable diseases and might be decreasing.

26 rveillance as a platform for surveillance of vaccine-preventable diseases and other outbreak-prone di

27 seline disease incidence can lead to a large vaccine-preventable disease burden and thus that populat

28 Adults are at substantial risk for vaccine-preventable disease, but their vaccination rates

29 Vaccine-preventable diseases cause more than 1 million d

30 tical role in describing the epidemiology of vaccine-preventable diseases, contributing to developmen

31 the implications of subpopulations for other vaccine-preventable disease eradication efforts.

32 that patients lose protective antibodies to vaccine-preventable diseases following allogeneic BMT an

33 United States target an increasing number of vaccine-preventable diseases for reduction, elimination,

34 n of national vaccine recommendations for 13 vaccine-preventable diseases for which recommendations w

35 ease processes such as emerging zoonoses and vaccine-preventable diseases, [Formula: see text] and in

36 ntial progress in reduction of the burden of vaccine-preventable diseases has been made, continued ca

37 World Health Organization Invasive Bacterial-Vaccine Preventable Diseases (IB-VPD) surveillance in Su

38 Hepatitis A is the most frequently reported vaccine-preventable disease in the United States.

39 Influenza is the most common vaccine-preventable disease in the United States; howeve

40 pulations in conflict settings, outbreaks of vaccine-preventable disease in these settings may persis

41 Recent outbreaks of vaccine-preventable diseases in the United States have d

42 on requirements are important in controlling vaccine-preventable diseases in the United States.

43 ents have played a major role in controlling vaccine-preventable diseases in the United States.

44 The number of cases of most vaccine-preventable diseases is at an all-time low; hosp

45 out adjustment for factors that could affect vaccine-preventable disease morbidity, mortality, or rep

46 Eradication efforts for vaccine-preventable diseases need to create performance

47 lear path to avoiding outbreaks of childhood vaccine-preventable diseases once the threat of Ebola be

48 istrict levels in areas deemed high risk for vaccine-preventable disease outbreaks.

49 lth Organization Technical Advisory Group on Vaccine Preventable Diseases recommended the implementat

50 reasons the 1997 Technical Advisory Group on Vaccine-Preventable Diseases recommended acceleration of

51 ndas in Nigeria, particularly the control of vaccine-preventable diseases, such as measles.

52 grating measles, neonatal tetanus, and other vaccine-preventable disease surveillance and their respe

53 80% or greater for cases and deaths of most vaccine-preventable diseases targeted since 1980 includi

54 Although influenza is a vaccine-preventable disease that annually causes substan

55 Seasonal influenza is a vaccine-preventable disease that remains a major health

56 omising strategy for the prevention of other vaccine-preventable diseases that threaten pregnant wome

57 odel to other global laboratory networks for vaccine-preventable diseases that will endure after the

58 onnel are at increased risk for transmitting vaccine-preventable diseases to their patients.

59 oordinates global laboratory surveillance of vaccine-preventable diseases (VPDs), including polio, me

60 During 1946-2005, vaccine-preventable diseases were the topic of approxima

61 ntestinal and foodborne infectious diseases, vaccine-preventable diseases, zoonotic and vectorborne d